|
|
| CP3A4_HUMAN |
CYP3A4 |
Cytochrome P450 3A4 |
0.0002597 |
1.00
|
| NR1I3_HUMAN |
NR1I3 |
Nuclear receptor subfamily 1 group I member 3 |
3.392e-170 |
0.73
|
| Q03732_HBV |
HBcAg |
Capsid protein |
1.645e-56 |
0.33
|
| PTGDS_MOUSE |
Ptgds |
Prostaglandin-H2 D-isomerase |
2.367e-44 |
0.34
|
| PDR5_YEAST |
PDR5 |
Pleiotropic ABC efflux transporter of multiple drugs |
1.641e-43 |
0.32
|
| CASR_HUMAN |
CASR |
Extracellular calcium-sensing receptor |
8.106e-40 |
0.35
|
| TERT_HUMAN |
TERT |
Telomerase reverse transcriptase |
4.029e-35 |
0.38
|
| TRPV4_HUMAN |
TRPV4 |
Transient receptor potential cation channel subfamily V member 4 |
8.168e-32 |
0.36
|
| CHLE_HUMAN |
BCHE |
Cholinesterase |
1.738e-28 |
0.53
|
| NK2R_HUMAN |
TACR2 |
Substance-K receptor |
2.148e-27 |
0.34
|
| HYES_HUMAN |
EPHX2 |
Bifunctional epoxide hydrolase 2 |
5.502e-27 |
0.38
|
| TSHR_HUMAN |
TSHR |
Thyrotropin receptor |
1.192e-25 |
0.34
|
| LYSC1_RAT |
Lyz1 |
Lysozyme C-1 |
1.342e-24 |
0.30
|
| TSHB_BOVIN |
TSHB |
Thyrotropin subunit beta |
1.125e-20 |
0.33
|
| NOX1_HUMAN |
NOX1 |
NADPH oxidase 1 |
3.845e-20 |
0.48
|
| AUKBA_XENLA |
aurkb-a |
Aurora kinase B-A |
2.322e-19 |
0.31
|
| 5HT2B_MOUSE |
Htr2b |
5-hydroxytryptamine receptor 2B |
2.621e-19 |
0.29
|
| KDM1B_HUMAN |
KDM1B |
Lysine-specific histone demethylase 1B |
2.621e-19 |
0.31
|
| BGLR_RAT |
Gusb |
Beta-glucuronidase |
4.682e-19 |
0.30
|
| EBPL_HUMAN |
EBPL |
Emopamil-binding protein-like |
4.682e-19 |
0.30
|
| CNR1_RAT |
Cnr1 |
Cannabinoid receptor 1 |
4.272e-18 |
0.35
|
| ADCY5_RAT |
Adcy5 |
Adenylate cyclase type 5 |
5.336e-18 |
0.33
|
| 5HT4R_RAT |
Htr4 |
5-hydroxytryptamine receptor 4 |
2.218e-17 |
0.36
|
| DPO3_BACSU |
polC |
DNA polymerase III PolC-type |
2.986e-14 |
0.34
|
| CDK13_HUMAN |
CDK13 |
Cyclin-dependent kinase 13 |
5.496e-14 |
0.29
|
| MRCKB_HUMAN |
CDC42BPB |
Serine/threonine-protein kinase MRCK beta |
5.496e-14 |
0.29
|
| MRCKG_HUMAN |
CDC42BPG |
Serine/threonine-protein kinase MRCK gamma |
5.496e-14 |
0.29
|
| PRKDC_HUMAN |
PRKDC |
DNA-dependent protein kinase catalytic subunit |
2.136e-13 |
0.37
|
| MK14_MOUSE |
Mapk14 |
Mitogen-activated protein kinase 14 |
3.275e-13 |
0.30
|
| 5HT2A_MOUSE |
Htr2a |
5-hydroxytryptamine receptor 2A |
1.482e-12 |
0.28
|
| THB_HUMAN |
THRB |
Thyroid hormone receptor beta |
3.804e-12 |
0.34
|
| CP51_MYCTU |
cyp51 |
Lanosterol 14-alpha demethylase |
9.956e-12 |
0.37
|
| HSP12_CAEEL |
hsp-16.2 |
Heat shock protein Hsp-16.2 |
1.199e-11 |
0.34
|
| DCNL1_HUMAN |
DCUN1D1 |
DCN1-like protein 1 |
1.377e-11 |
0.30
|
| CALM_BOVIN |
CALM |
Calmodulin |
2.873e-11 |
0.30
|
| TRPV4_MOUSE |
Trpv4 |
Transient receptor potential cation channel subfamily V member 4 |
3.108e-11 |
0.33
|
| DEFM_HUMAN |
PDF |
Peptide deformylase, mitochondrial |
3.225e-11 |
0.31
|
| ABC3A_HUMAN |
APOBEC3A |
DNA dC->dU-editing enzyme APOBEC-3A |
3.785e-11 |
0.39
|
| HSPB1_HUMAN |
HSPB1 |
Heat shock protein beta-1 |
7.655e-11 |
0.29
|
| FAAH1_HUMAN |
FAAH |
Fatty-acid amide hydrolase 1 |
1.656e-10 |
0.31
|
| CNR2_HUMAN |
CNR2 |
Cannabinoid receptor 2 |
3.479e-10 |
0.38
|
| DRD3_HUMAN |
DRD3 |
D(3) dopamine receptor |
3.998e-10 |
0.42
|
| ANKK1_HUMAN |
ANKK1 |
Ankyrin repeat and protein kinase domain-containing protein 1 |
4.287e-10 |
0.29
|
| NOS1_HUMAN |
NOS1 |
Nitric oxide synthase, brain |
5.366e-10 |
0.36
|
| Q3Y5H1_9GAMC |
|
3C-like protease |
7.319e-10 |
0.30
|
| MUSK_HUMAN |
MUSK |
Muscle, skeletal receptor tyrosine-protein kinase |
8.03e-10 |
0.29
|
| CDKL3_HUMAN |
CDKL3 |
Cyclin-dependent kinase-like 3 |
9.309e-10 |
0.28
|
| 5HT1A_MOUSE |
Htr1a |
5-hydroxytryptamine receptor 1A |
1.193e-09 |
0.29
|
| KCNK2_HUMAN |
KCNK2 |
Potassium channel subfamily K member 2 |
1.496e-09 |
0.30
|
| MAK_HUMAN |
MAK |
Serine/threonine-protein kinase MAK |
4.372e-09 |
0.28
|
| G3I1B6_CRIGR |
|
5-hydroxytryptamine receptor |
4.541e-09 |
0.33
|
| HRH1_HUMAN |
HRH1 |
Histamine H1 receptor |
4.609e-09 |
0.42
|
| CCKAR_RAT |
Cckar |
Cholecystokinin receptor type A |
5.263e-09 |
0.36
|
| CNR1_HUMAN |
CNR1 |
Cannabinoid receptor 1 |
5.291e-09 |
0.35
|
| 5HT1B_CRIGR |
HTR1B |
5-hydroxytryptamine receptor 1B |
5.78e-09 |
0.33
|
| MK15_HUMAN |
MAPK15 |
Mitogen-activated protein kinase 15 |
6.701e-09 |
0.29
|
| ABC3G_HUMAN |
APOBEC3G |
DNA dC->dU-editing enzyme APOBEC-3G |
6.871e-09 |
0.39
|
| 5HT2C_MOUSE |
Htr2c |
5-hydroxytryptamine receptor 2C |
8.815e-09 |
0.29
|
| EPHA7_HUMAN |
EPHA7 |
Ephrin type-A receptor 7 |
1.053e-08 |
0.29
|
| CAC1G_HUMAN |
CACNA1G |
Voltage-dependent T-type calcium channel subunit alpha-1G |
1.285e-08 |
0.32
|
| FNTB_HUMAN |
FNTB |
Protein farnesyltransferase subunit beta |
1.308e-08 |
0.34
|
| SCRB1_HUMAN |
SCARB1 |
Scavenger receptor class B member 1 |
1.424e-08 |
0.29
|
| CALM1_HUMAN |
CALM1 |
Calmodulin-1 |
1.462e-08 |
0.30
|
| CHLE_HORSE |
BCHE |
Cholinesterase |
1.541e-08 |
0.41
|
| EPHA5_HUMAN |
EPHA5 |
Ephrin type-A receptor 5 |
1.612e-08 |
0.29
|
| MK14_HUMAN |
MAPK14 |
Mitogen-activated protein kinase 14 |
1.698e-08 |
0.35
|
| KLK6_HUMAN |
KLK6 |
Kallikrein-6 |
1.968e-08 |
0.30
|
| HKDC1_HUMAN |
HKDC1 |
Hexokinase HKDC1 |
2.421e-08 |
0.33
|
| EPHA8_HUMAN |
EPHA8 |
Ephrin type-A receptor 8 |
3.532e-08 |
0.29
|
| EPHB3_HUMAN |
EPHB3 |
Ephrin type-B receptor 3 |
3.532e-08 |
0.29
|
| MET_HUMAN |
MET |
Hepatocyte growth factor receptor |
4.009e-08 |
0.40
|
| FNTA_HUMAN |
FNTA |
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha |
4.508e-08 |
0.34
|
| NEK9_HUMAN |
NEK9 |
Serine/threonine-protein kinase Nek9 |
4.728e-08 |
0.28
|
| ABL1_MOUSE |
Abl1 |
Tyrosine-protein kinase ABL1 |
6.236e-08 |
0.34
|
| PABP1_HUMAN |
PABPC1 |
Polyadenylate-binding protein 1 |
6.465e-08 |
0.39
|
| DRD2_HUMAN |
DRD2 |
D(2) dopamine receptor |
6.532e-08 |
0.38
|
| TBK1_HUMAN |
TBK1 |
Serine/threonine-protein kinase TBK1 |
6.834e-08 |
0.33
|
| 5HT2A_HUMAN |
HTR2A |
5-hydroxytryptamine receptor 2A |
7.139e-08 |
0.42
|
| EPHA4_HUMAN |
EPHA4 |
Ephrin type-A receptor 4 |
7.153e-08 |
0.29
|
| 5HT1A_HUMAN |
HTR1A |
5-hydroxytryptamine receptor 1A |
7.733e-08 |
0.42
|
| SOAT1_HUMAN |
SOAT1 |
Sterol O-acyltransferase 1 |
8.574e-08 |
0.29
|
| ACES_HUMAN |
ACHE |
Acetylcholinesterase |
9.185e-08 |
0.39
|
| CTRO_HUMAN |
CIT |
Citron Rho-interacting kinase |
9.923e-08 |
0.29
|
| NLK_HUMAN |
NLK |
Serine/threonine-protein kinase NLK |
9.923e-08 |
0.29
|
| NK2R_CAVPO |
TACR2 |
Substance-K receptor |
9.989e-08 |
0.29
|
| LIPL_RAT |
Lpl |
Lipoprotein lipase |
1.031e-07 |
0.29
|
| PD2R_MOUSE |
Ptgdr |
Prostaglandin D2 receptor |
1.033e-07 |
0.30
|
| CAN2_HUMAN |
CAPN2 |
Calpain-2 catalytic subunit |
1.187e-07 |
0.34
|
| CDKL5_HUMAN |
CDKL5 |
Cyclin-dependent kinase-like 5 |
1.212e-07 |
0.28
|
| MYO3A_HUMAN |
MYO3A |
Myosin-IIIa |
1.212e-07 |
0.28
|
| EPHA1_HUMAN |
EPHA1 |
Ephrin type-A receptor 1 |
1.826e-07 |
0.29
|
| EPHB1_HUMAN |
EPHB1 |
Ephrin type-B receptor 1 |
1.826e-07 |
0.29
|
| AURKB_HUMAN |
AURKB |
Aurora kinase B |
2.001e-07 |
0.31
|
| ATM_HUMAN |
ATM |
Serine-protein kinase ATM |
2.108e-07 |
0.41
|
| NPBW1_HUMAN |
NPBWR1 |
Neuropeptides B/W receptor type 1 |
2.188e-07 |
0.42
|
| TNIK_HUMAN |
TNIK |
TRAF2 and NCK-interacting protein kinase |
2.222e-07 |
0.35
|
| EPHA6_HUMAN |
EPHA6 |
Ephrin type-A receptor 6 |
2.427e-07 |
0.29
|
| CD11A_HUMAN |
CDK11A |
Cyclin-dependent kinase 11A |
2.753e-07 |
0.28
|
| MYO3B_HUMAN |
MYO3B |
Myosin-IIIb |
2.753e-07 |
0.28
|
| IKKE_HUMAN |
IKBKE |
Inhibitor of nuclear factor kappa-B kinase subunit epsilon |
2.941e-07 |
0.33
|
| EPHB2_HUMAN |
EPHB2 |
Ephrin type-B receptor 2 |
3.186e-07 |
0.29
|
| TIE1_HUMAN |
TIE1 |
Tyrosine-protein kinase receptor Tie-1 |
5.311e-07 |
0.29
|
| 5HT2C_HUMAN |
HTR2C |
5-hydroxytryptamine receptor 2C |
8.573e-07 |
0.42
|
| NPY1R_HUMAN |
NPY1R |
Neuropeptide Y receptor type 1 |
8.843e-07 |
0.31
|
| ACM5_RAT |
Chrm5 |
Muscarinic acetylcholine receptor M5 |
8.948e-07 |
0.31
|
| HUNK_HUMAN |
HUNK |
Hormonally up-regulated neu tumor-associated kinase |
1.08e-06 |
0.28
|
| HPGDS_HUMAN |
HPGDS |
Hematopoietic prostaglandin D synthase |
1.553e-06 |
0.31
|
| ACHA7_RAT |
Chrna7 |
Neuronal acetylcholine receptor subunit alpha-7 |
1.665e-06 |
0.38
|
| CDK19_HUMAN |
CDK19 |
Cyclin-dependent kinase 19 |
1.877e-06 |
0.30
|
| CD11B_HUMAN |
CDK11B |
Cyclin-dependent kinase 11B |
1.924e-06 |
0.28
|
| CDK15_HUMAN |
CDK15 |
Cyclin-dependent kinase 15 |
1.924e-06 |
0.28
|
| DDR2_HUMAN |
DDR2 |
Discoidin domain-containing receptor 2 |
2.165e-06 |
0.29
|
| NMDE1_HUMAN |
GRIN2A |
Glutamate receptor ionotropic, NMDA 2A |
2.675e-06 |
0.33
|
| NAMPT_HUMAN |
NAMPT |
Nicotinamide phosphoribosyltransferase |
3.082e-06 |
0.34
|
| CDK18_HUMAN |
CDK18 |
Cyclin-dependent kinase 18 |
3.24e-06 |
0.28
|
| P3C2G_HUMAN |
PIK3C2G |
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma |
3.31e-06 |
0.28
|
| PTN13_HUMAN |
PTPN13 |
Tyrosine-protein phosphatase non-receptor type 13 |
3.597e-06 |
0.28
|
| MMP13_BOVIN |
MMP13 |
Collagenase 3 |
3.723e-06 |
0.34
|
| STK10_HUMAN |
STK10 |
Serine/threonine-protein kinase 10 |
4.092e-06 |
0.29
|
| EPHA3_HUMAN |
EPHA3 |
Ephrin type-A receptor 3 |
4.84e-06 |
0.29
|
| AOFA_RAT |
Maoa |
Amine oxidase [flavin-containing] A |
5.135e-06 |
0.33
|
| RIPK4_HUMAN |
RIPK4 |
Receptor-interacting serine/threonine-protein kinase 4 |
5.202e-06 |
0.28
|
| ABL2_HUMAN |
ABL2 |
Tyrosine-protein kinase ABL2 |
5.694e-06 |
0.29
|
| RAD52_HUMAN |
RAD52 |
DNA repair protein RAD52 homolog |
6.145e-06 |
0.33
|
| ADA1D_HUMAN |
ADRA1D |
Alpha-1D adrenergic receptor |
7.088e-06 |
0.36
|
| GPR55_HUMAN |
GPR55 |
G-protein coupled receptor 55 |
7.401e-06 |
0.34
|
| INSRR_HUMAN |
INSRR |
Insulin receptor-related protein |
8.016e-06 |
0.28
|
| M3K4_HUMAN |
MAP3K4 |
Mitogen-activated protein kinase kinase kinase 4 |
8.016e-06 |
0.28
|
| MYLK3_HUMAN |
MYLK3 |
Myosin light chain kinase 3 |
8.016e-06 |
0.28
|
| RAF1_HUMAN |
RAF1 |
RAF proto-oncogene serine/threonine-protein kinase |
8.051e-06 |
0.31
|
| DRD4_MOUSE |
Drd4 |
D(4) dopamine receptor |
8.684e-06 |
0.28
|
| PCNA_HUMAN |
PCNA |
Proliferating cell nuclear antigen |
8.695e-06 |
0.29
|
| PTN5_HUMAN |
PTPN5 |
Tyrosine-protein phosphatase non-receptor type 5 |
9.533e-06 |
0.34
|